Do I Need Labs While Waiting for an Endocrinologist?

Your primary care doctor looked over your bloodwork and called it fine. The endocrinologist you were referred to has a first opening three months out. Your plan carries a deductible somewhere between $5,000 and $10,000, so in practice you pay for every visit and every test yourself.

That leaves a practical question. If your doctor says your results are normal, do you need more labs at all? If the money comes out of your own pocket either way, are labs while waiting for an endocrinologist worth paying for?

This piece follows a composite reader drawn from that situation. No real patient is described. The honest answer is that more testing sometimes changes nothing. Sometimes it is the first time anyone measures the markers behind the referral. GoodLife Health is a clinician-led, flat-fee membership that pairs with your insurance for catastrophic cover and replaces the primary-care relationship. It includes four cardiometabolic lab panels a year, with every result in your hands.

Three months, a large deductible and a result called fine

The referral came for a reason. It may have been a value at the edge of its range, a symptom that would not settle or a family history someone finally wrote down. Whatever it was, the doctor who ordered your last panel judged it worth a specialist's time. The same doctor told you the panel was normal. Both statements can be true at once. The space between them is where the next three months will go.

A three-month wait is long for anyone. On a high-deductible plan, it also costs money in a particular way. Until the deductible is met, each visit and each test is a bill you pay yourself. In a healthy year, many people on these plans never reach the deductible at all. For them the insurance guards against a hospital bill and does little for the ordinary work of staying well. KFF follows what employers offer, deductibles included, in its 2025 Employer Health Benefits Survey.

So every decision about care becomes a purchasing decision. You weigh a repeat test the way you would weigh any other expense you cannot return. That is a sensible way to think. This piece takes the same view and asks what each dollar of the next three months returns.

You have also seen what an ordinary visit buys. A traditional primary care visit runs 15 to 20 minutes and is built around one complaint, as our guide to what a direct primary care visit actually looks like describes. In that window, a doctor reads a results page, looks for anything flagged outside its range and tells you whether something needs doing. If nothing is flagged, the word is fine. You leave with a bill and no new information about where you are heading.

Meanwhile, the specialist's calendar does not move. When the appointment finally comes, it is one visit with one clinician who has limited time of their own. The specialist may order tests that were never drawn. Then you wait again for those results and for a follow-up to discuss them. Each step is another bill under the deductible.

None of this is anyone's failure. Your doctor read the panel that was ordered. The endocrinology office booked the next opening it had. Each part of the system did its job. What the system does not do is follow your markers between visits. Nobody in it is paid to.

What a normal result does and does not tell you

On a lab report, normal has a narrow meaning. It says your value fell inside the reference range, the band the lab reports as expected across a reference group of people. It describes where you sit within a population. Normal is a population range. You are not a population. A single normal result says little about whether a value suits you, which way it is moving or how it reads beside the markers nobody ordered.

Three questions are worth asking about any panel called fine.

The first is what was measured. A routine panel is often built around glucose and a standard cholesterol profile. The markers cardiometabolic care has moved toward are usually ordered separately, if they are ordered at all. They are ApoB, Lipoprotein(a), hs-CRP and fasting insulin. A panel can be entirely normal and still leave every one of them unmeasured. The list of tests tells you more than the word fine does. Ask the office for it.

The second is direction. One reading is a snapshot. A value near the top of its range this year and near the bottom last year is normal both times. Only the pair tells you that it moved and which way. With a single draw, there is no direction to read. That matters most for the slow changes that cardiometabolic disease is made of.

The third is relationship. Our definitive guide to cardiometabolic optimization describes weight, thyroid function, blood sugar, insulin, lipids and inflammation as one connected system. In the guide's words, insulin resistance drives weight gain. That is why GoodLife Health measures fasting insulin, so the picture is visible before glucose turns abnormal. When each marker is read alone, each can look acceptable while the system as a whole drifts.

The direction of the field shows in the numbers. More than 130 million American adults live with diabetes or prediabetes, according to the CDC's National Diabetes Statistics Report. In NHANES data from 2009 to 2016, only 12% of U.S. adults were metabolically healthy. Those figures are why medicine is moving toward testing before treating. ApoB and fasting insulin are taking the place in the conversation that LDL and glucose used to hold alone.

None of this means your doctor missed something. Your results may be as fine as you were told. We do not know. Neither does anyone else until the markers are drawn and read by someone who will see the next set too.

Timing matters for you in particular. The value of one endocrinology appointment depends heavily on what the specialist has in front of them. A current, broader panel and a clinician's reading of it give that visit more to work with than a single result called fine. Three months of waiting can stay empty. They can also be the first quarter of a record.

What the membership does with those three months

GoodLife Health pairs with your insurance for catastrophic cover and replaces the primary-care relationship. Keep the high-deductible plan for the hospital and the bad year. The membership is the clinician you could not reach.

It starts with labs. Four cardiometabolic lab panels are drawn each year, one every 90 days. The panel includes Apolipoprotein B (ApoB), Lipoprotein (A), Hs-CRP, Hemoglobin A1c (HbA1c), Fasting Insulin, TSH With Reflex To Free T4 and more. Every result goes into your hands. Results are read against optimal ranges, the approach our definitive guide describes, by a clinician who stays with you from one quarter to the next. Between draws, you reach the care team by asynchronous message. Video visits cover what needs a conversation.

If you are accepted, care begins with the first panel. Inside a three-month wait, that panel and the clinician's reading of it can come before the specialist ever sees you. Some of what prompted the referral may sit within cardiometabolic care. Thyroid results are followed every quarter, with thyroid medication where indicated. HbA1c is followed every quarter, with branded medication, including Mounjaro, where indicated. The clinician will tell you which parts of your situation fall within that scope and which still belong with the endocrinologist. Keep the appointment and bring the results.

When a medication is indicated, it is branded and FDA-approved. It is prescribed to the pharmacy you choose and priced by that pharmacy. GoodLife Health sets nothing, sees nothing and takes nothing on medication. The fee is the same whatever medication is indicated and whatever the dose. For someone who pays out of pocket, that means the price you see is the pharmacy's own. In September 2026, NovoCare listed Wegovy pens at $199 a month for the first two fills (an introductory offer for new patients through December 2026) with $349 a month after. Whether your plan covers any medication is between you, the plan and the pharmacy. Prior authorization, where a plan asks for it, is the pharmacy's process.

Two insurance questions come up on a plan like yours. The first is whether the membership replaces the plan. It does not. The membership is a flat monthly fee that sits beside your insurance, which stays in place for the hospital and the emergency. The second is whether a health savings or flexible spending account can pay for it. We don't promise the membership fee is HSA or FSA eligible. Your account administrator decides, so check with them before using those funds.

The membership is $299 a month. At sign-up, $598 is held on your card to cover the first two months. It is a hold. It is charged only once a clinician accepts you into care. If the clinician cannot accept you, the hold is released and you are never charged. Once you are accepted, the first two months are charged and are non-refundable. From the third month, the membership is month to month. A full year of membership is $3,588. Medication billed by a pharmacy follows that pharmacy's own return and refund policy.

The membership has limits. It does not replace your insurance. It does not replace an endocrinologist where you need one. It promises no diagnosis, no particular result and no coverage of a medication. Not everyone is accepted. The path runs from the eligibility check to the intake, the checkout and then a clinician's review. It is precision direct primary care for cardiometabolic health, which is narrower than full-scope primary care. On price, it sits between the $20,000-a-year concierge practice and the $99-a-month compounded app.

What to do before the appointment

Whether or not you join, the next three months can be put to use. Start this week.

1. Ask your primary care office for a copy of your last results with the full list of tests on the panel.
2. Check that list for ApoB, Lipoprotein(a), hs-CRP and fasting insulin. If they are missing, write that down as a question for the specialist.
3. Write a one-page summary of what led to the referral, with dates, symptoms and any results that sat near the edge of a range.
4. Ask the endocrinology office whether it keeps a cancellation list. An earlier slot sometimes opens.
5. Keep the appointment, whatever else you decide.

A summary and a list of missing tests cost nothing. On their own, they make a short specialist visit more useful. If you want the missing markers drawn and read before that visit by a clinician who will also read the next set, that is what the membership is for.

The membership is $299 a month. At sign-up, $598 is held for the first two months and charged only once a clinician accepts you. If you are not accepted, the hold is released and you are never charged. Once you are accepted, those two months are charged and are non-refundable. After them, the membership is month to month. It buys the quarterly panel, a clinician who stays and medication prescribed to your pharmacy at that pharmacy's price, with nothing taken on it. It is built to return the diagnosis a visit never produced, your markers followed over time and an end to the eight-minute visit. It is different because it tests first, treats second and sells neither the drug nor the dose. Your appointment is three months away, which is one quarterly cycle. You are paying for care yourself either way, so the real question is what those three months return.

Who this is not for

If you want a prescription without labs at the lowest possible monthly price, this membership is not for you. We would rather say so here than after checkout. The fee pays for testing first and for a clinician who stays. GoodLife Health sells neither the drug nor the dose and earns nothing on either, which is why the price is what it is.

It is also not for you if a clinician you trust already follows your markers over time and reads them with you. Keep that clinician. It is not for you if you want your insurance replaced, a guaranteed result or care outside cardiometabolic health. Anything urgent belongs with emergency care. The membership is available only to residents of the United States.

Related Reading

• Cardiometabolic Optimization: The Definitive Guide
• What a Direct Primary Care Visit Actually Looks Like (2026)

References

1. 2025 Employer Health Benefits Survey — Kaiser Family Foundation. 2025. www.kff.org/health-costs/2025-employer-health-benefits-survey/
2. NovoCare Pharmacy — Wegovy self-pay pricing (Novo Nordisk). 2026. www.novocare.com/pharmacy/wegovy.html